DMII Drugs Made in America Acquisition Ii Corp.

Fundamentals / CIK 0002040475 / USD
Other share classes on CIK 0002040475: DMIIR DMIIU

Drugs Made in America Acquisition Ii Corp. reported $518.7M in total assets and net income of $17.68M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DMII in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31
Total Operating Expenses $488K
Operating Income -$488K
Interest Income $4.93M
Net Income $4.19M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Total Operating Expenses $77K $112K $132K $235K $156K $38K $59K
Operating Income -$77K -$112K -$132K -$235K -$156K -$38K -$59K
Interest Income $4.70M $4.51M $4.44M -- $109K -- --
Net Income $4.62M $4.40M $4.34M $4.33M -$46K -$38K -$59K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $223 $17K
Cash & Short-Term Investments $223 $17K
Total Current Assets $26K $60K
Total Non-Current Assets $504.9M $78K
Total Assets $505.0M $138K
Accounts Payable $99K --
Other Current Liabilities $0 --
Total Current Liabilities $301K $255K
Total Non-Current Liabilities $17.50M $0
Total Liabilities $17.80M $255K
Common Stock $1.4K $1.4K
Retained Earnings -$17.78M -$152K
Total Stockholders' Equity -$17.77M -$117K
Total Equity -$17.77M -$117K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2024-12-31
Cash & Cash Equivalents -- $175K $348K $223 $315K $17K
Cash & Short-Term Investments -- $175K $348K $223 $315K $17K
Total Current Assets $140K $218K $352K $26K $896K $60K
Total Non-Current Assets $518.6M $513.9M $509.4M $504.9M $500.1M $78K
Total Assets $518.7M $514.1M $509.7M $505.0M $501.0M $138K
Accounts Payable $79K $12K $49K $99K $4.6K --
Short-Term Debt -- $450K $450K -- -- --
Other Current Liabilities -- -- -- $0 $554K --
Total Current Liabilities $643K $645K $666K $301K $677K $255K
Total Non-Current Liabilities $17.50M $17.50M $17.50M $17.50M $17.50M $0
Total Liabilities $18.14M $18.14M $18.17M $17.80M $18.18M $255K
Total Debt (incl. Leases) -- $450K $450K -- -- --
Common Stock $1.4K $1.4K $1.4K $1.4K $1.6K $1.4K
Retained Earnings -$18.01M -$17.93M -$17.82M -$17.78M -$17.28M -$152K
Total Stockholders' Equity -$18.00M -$17.93M -$17.81M -$17.77M -$17.28M -$117K
Total Equity -$18.00M -$17.93M -$17.81M -$17.77M -$17.28M -$117K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31
Net Income $4.19M
Change in Payables $99K
Operating Cash Flow -$1.02M
Investing Cash Flow -$500.0M
Financing Cash Flow $501.0M
Net Change in Cash -$17K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Net Income $4.62M $4.40M $4.34M $4.33M -$46K -$38K -$59K
Change in Payables -- -$22K -$22K $95K $2.4K -$9.1K $11K
Operating Cash Flow -$57K -$173K -$103K -$315K -$691K -$2.6K -$10K
Financing Cash Flow $0 $0 $450K -- -- -- --
Net Change in Cash -$57K -$173K $347K -$315K $311K -$2.6K -$10K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31
Return on Assets (ROA) 0.8%
Current Ratio 0.09x
Quick Ratio 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Return on Assets (ROA) 3.4% 2.5% 1.7% 0.8% -- -- --
Current Ratio 0.22x 0.34x 0.53x 0.09x 1.32x -- --
Quick Ratio -- 0.27x 0.52x 0.00x 0.47x -- --
Source: SEC EDGAR CompanyFacts (CIK 0002040475) · from December 31, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:34 UTC · Open in terminal